Symmetrel
Symmetrel is a medicine authorised by Swissmedic under authorisation number 31841. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 October 1966 and the authorisation is valid without a time limit. ATC code N04BB01 places the medicine in the group Anti-Parkinson drugs.
| Authorisation number | 31841 |
|---|---|
| Name | Symmetrel |
| Full name | Symmetrel, Kapseln |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N04BB01 |
| First authorisation | 15 October 1966 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Symmetrel, Kapseln | B | 15 October 1966 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 38 | 60 | Kapsel(n) | N04BB01 | 01.08.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Symmetrel authorised in Switzerland?
Yes. Symmetrel is authorised by Swissmedic under authorisation number 31841, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Symmetrel have?
Symmetrel is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Symmetrel?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.